Clinical trial of a prion disease drug candidate begins enrolling participants
(www.broadinstitute.org)
Good, I can go back to eating brains.
Good, I can go back to eating brains.
Zombie apocalypse for Christmas.
The new drug candidate, developed by Broad Institute and University of Massachusetts Chan Medical School scientists, is a small interfering RNA (siRNA) that binds and snips RNA molecules encoding the prion protein, reducing the amount of the disease-causing protein in the brain. Previous research in animals has shown that lowering prion protein levels can delay onset and slow down the disease.
Fascinating
all 4 comments